BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 17117283)

  • 1. Bone quality: what is it and how is it measured?
    Compston J
    Arq Bras Endocrinol Metabol; 2006 Aug; 50(4):579-85. PubMed ID: 17117283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone quality and osteoporosis therapy.
    Martin RM; Correa PH
    Arq Bras Endocrinol Metabol; 2010 Mar; 54(2):186-99. PubMed ID: 20485908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of osteoporosis. Antiresorptive therapy.
    Miller PD
    Clin Lab Med; 2000 Sep; 20(3):603-22, viii. PubMed ID: 10986624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management.
    Felsenberg D; Boonen S
    Clin Ther; 2005 Jan; 27(1):1-11. PubMed ID: 15763602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Frontiers in vitamin D; basic research and clinical application. Eldecalcitol: the effect on bones and calcium metabolism].
    Endo I; Matsumoto T
    Clin Calcium; 2011 Nov; 21(11):103-10. PubMed ID: 22040826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone density vs bone quality: what's a clinician to do?
    Licata A
    Cleve Clin J Med; 2009 Jun; 76(6):331-6. PubMed ID: 19487553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Menopause and bone].
    Lobersztajn A; Trémollières F
    J Gynecol Obstet Biol Reprod (Paris); 2012 Nov; 41(7 Suppl):F28-32. PubMed ID: 23036315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is bone mineral density predictive of fracture risk reduction?
    Cefalu CA
    Curr Med Res Opin; 2004 Mar; 20(3):341-9. PubMed ID: 15025843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of bone quality. Bone quality and osteoporosis treatment].
    Mashiba T
    Clin Calcium; 2008 Mar; 18(3):300-7. PubMed ID: 18310816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bone remodeling].
    Lerner UH; Ljunggren O
    Lakartidningen; 2006 Oct 4-10; 103(40):2972-5. PubMed ID: 17115661
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative effects of antiresorptive agents on bone mineral density and bone turnover in postmenopausal women.
    Jordan N; Barry M; Murphy E
    Clin Interv Aging; 2006; 1(4):377-87. PubMed ID: 18046915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Physiology and bone physiopathology].
    Lafita J
    An Sist Sanit Navar; 2003; 26 Suppl 3():7-15. PubMed ID: 14716355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New bone density conservation agents for osteoporosis under research and development: Minodronic acid].
    Takata S
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():417-20. PubMed ID: 18161142
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diagnosis and treatment of immobilization osteoporosis].
    Inoue D
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():514-9. PubMed ID: 18159714
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of denosumab on bone mineral density and bone turnover in postmenopausal women.
    Wensel TM; Iranikhah MM; Wilborn TW
    Pharmacotherapy; 2011 May; 31(5):510-23. PubMed ID: 21923432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bone histomorphometry;A role of evaluation for bone quality and mechanical strength].
    Yamamoto N; Takahashi H; Shimakura T
    Clin Calcium; 2016 Jan; 26(1):9-15. PubMed ID: 26728526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New therapeutical horizons in the management of postmenopausal osteoporosis.
    Migliaccio S; Fornari R; Greco EA; Di Luigi L; Lenzi A
    Aging Clin Exp Res; 2013 Oct; 25 Suppl 1():S117-9. PubMed ID: 24048905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmenopausal osteoporosis: the role of immune system cells.
    Faienza MF; Ventura A; Marzano F; Cavallo L
    Clin Dev Immunol; 2013; 2013():575936. PubMed ID: 23762093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are we treating women with postmenopausal osteoporosis for their low BMD or high fracture risk?
    Bone HG; Santora AC; Chattopadhyay A; Liberman U
    J Bone Miner Res; 2005 Nov; 20(11):2064-5. PubMed ID: 16234982
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical utility of bone markers in the evaluation and follow-up of osteoporotic patients: why are the markers poorly accepted by clinicians?
    Stepan JJ
    J Endocrinol Invest; 2003 May; 26(5):458-63. PubMed ID: 12906375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.